m-RECIST at 1 month and Child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinoma

m-RECIST at 1 month and Child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinoma

Background and aims. Percutaneous ethanol injection (PEI) is a well-established therapeutic option in patients with cirrhosis and hepatocellular carcinoma (HCC). The modified-Response Evaluation Criteria in Solid Tumors (m-RECIST) are an important tool for the assessment of HCC response to therapy....

Full description

Bibliographic Details
Main Authors: Mauricio F. Silva, Flair J. Carrilho, Denise C. Paranaguá-Vezozzo, Luciana T. Campos, Lucas S. Nacif, Marcio A. Diniz, Alberto Q. Farias, Venancio A.F. Alves, Luis A.C. D’Alburquerque, Suzane K. Ono
Format: Article
Language:English
Published: Elsevier 2014-11-01
Series:Annals of Hepatology
Subjects:
Liver cancer
Percutaneous ablation
Radiological response
Curative treatment
Clinical decision-making
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119309822

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119309822

Similar Items